Plain Prescription Prices Act
HR 4623, the Plain Prescription Prices Act, requires drug companies to include the current list price for a typical 30-day supply or treatment course in all direct-to-consumer television ads for prescription drugs covered by Medicare (Part D) or Medicaid. This applies to ads aired on broadcast, cable, streaming, or satellite TV. The bill mandates that the displayed price must be truthful and reflect the list price as of the first day of the quarter the ad runs. The goal is to provide consumers with clear, upfront pricing information when viewing drug advertisements.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2025
Committee Review
Floor Vote
President
Introduced Jul 22, 2025
Last action Jul 22, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jul 22, 2025
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jul 22, 2025
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Nikema Williams
DDemocratic
Co
Angie Craig
DDemocratic
Co
Bryan Steil
RRepublican
Co
Don Bacon
RRepublican
Co
Tom Barrett
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 4623
Scope: US
Hi! I can help you understand HR 4623. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline